Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> AVASTIN Latest News

JUN 02, 2014 - MedPage Today

A Must Read - Share

ASCO: Chemo Plus Avastin or Erbitux Boosts Colorectal Ca Survival

CHICAGO (MedPage Today) -- Treatment with either cetuximab or bevacizumab and standard chemotherapy produced a median survival of about 2.5 years among patients with advanced metastatic colorectal cancer, according to results of a long-term clinical trial.

Tags: ASCO: Chemo Plus Avastin or Erbitux Boosts Colorectal Ca Survival,  Avastin Latest News